Show simple item record

dc.contributor.authorMcilroy, George D
dc.contributor.authorMitchell, Sharon E
dc.contributor.authorHan, Weiping
dc.contributor.authorDelibegović, Mirela
dc.contributor.authorRochford, Justin J
dc.date.accessioned2020-01-23T16:10:01Z
dc.date.available2020-01-23T16:10:01Z
dc.date.issued2020-01-17
dc.identifier.citationMcilroy , G D , Mitchell , S E , Han , W , Delibegović , M & Rochford , J J 2020 , ' Ablation of Bscl2/Seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy ' , Disease Models & Mechanisms , vol. 13 , no. 1 , dmm042655 . https://doi.org/10.1242/dmm.042655en
dc.identifier.issn1754-8403
dc.identifier.otherPURE: 152454206
dc.identifier.otherPURE UUID: 56e2f1a0-b1dc-4fbe-a6d2-22722518189d
dc.identifier.otherPubMed: 31848133
dc.identifier.otherPubMed: 31848133
dc.identifier.otherScopus: 85078504837
dc.identifier.otherWOS: 000512345300007
dc.identifier.otherORCID: /0000-0002-5020-4939/work/79062189
dc.identifier.urihttps://hdl.handle.net/2164/13584
dc.descriptionFunding Work was supported by the Medical Research Council (GDM/JJR; MR/L002620/1, MC/PC/15077), the Biotechnology and Biological Sciences Research Council (JJR; BB/K017772/1), Diabetes UK (GDM/JJR; 18/0005884), the British Heart Foundation (MD;PG/14/43/30889) and the Wellcome Trust and the University of Aberdeen ISSF Fund (GDM; ISSF Fellowship Support Fund).en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofDisease Models & Mechanismsen
dc.rightshttps://creativecommons.org/licenses/by/4.0/en
dc.subjectLipodystrophyen
dc.subjectBSCL2CGLen
dc.subjectHepatocyteen
dc.subjectAAVen
dc.subjectCRISPRen
dc.subjectBSCL2en
dc.subjectCGLen
dc.subjectINSULIN SENSITIVITYen
dc.subjectSEIPINen
dc.subjectLIPOLYSISen
dc.subjectRESISTANCEen
dc.subjectMICEen
dc.subjectKNOCKOUTen
dc.subjectR Medicineen
dc.subjectImmunology and Microbiology (miscellaneous)en
dc.subjectBiochemistry, Genetics and Molecular Biology(all)en
dc.subjectNeuroscience (miscellaneous)en
dc.subjectMedicine (miscellaneous)en
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/L002620/1en
dc.subjectMC/PC/15077en
dc.subjectBiotechnology and Biological Sciences Research Council (BBSRC)en
dc.subjectBB/K017772/1en
dc.subjectBritish Heart Foundationen
dc.subjectMD;PG/14/43/30889en
dc.subjectWellcome Trusten
dc.subjectISSF Fellowship Support Funden
dc.subject.lccRen
dc.titleAblation of Bscl2/Seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Biological Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Vice Principalsen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1242/dmm.042655
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85078504837&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record